Dagandang, Roselyn L.
HRN: 26-16-89 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2024
CEFUROXIME 1.5GM (VIAL)
11/08/2024
11/14/2024
IV
1.5g
Q8
UTI
Waiting Final Action